Minerva Neurosciences reported $13.5M in Market Capitalization this February of 2023, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 2.65B 373M
Adma Biologics ADMA:US USD 478M 89M
ALKERMES ALKS:US USD 3.67B 1.23B
AstraZeneca AZN:LN USD 154.08B 13.26B
Biocryst Pharmaceuticals BCRX:US USD 2.34B 376M
Bristol Myers Squibb BMY:US USD 152.98B 1.18B
Dynavax Technologies DVAX:US USD 1.32B 270M
Eli Lilly And LLY:US USD 347.61B 40.37B
Esperion Therapeutics ESPR:US USD 446M 45M
GlaxoSmithKline GSK:LN GBP 58.86B 5.75B
Halozyme Therapeutics HALO:US USD 5.45B 622M
IONIS PHARMACEUT IONS:US USD 6.28B 1.03B
Johnson & Johnson JNJ:US USD 461.85B 32.35B
Marinus Pharmaceuticals MRNS:US USD 247M 67M
Merk MRK:US USD 281.3B 63.14B
Minerva Neurosciences NERV:US USD 49M 31M
Neurocrine Biosciences NBIX:US USD 10.16B 841M
Novartis NOVN:VX USD 181.55B 12.79B
Novavax NVAX:US USD 1.42B 2.6B
Pfizer PFE:US USD 287.63B 42.03B
Roche Holding ROG:VX CHF 263.11B 68.64B
Sanofi SAN:FP EUR 99.37B 22.52B
Takeda 4502:JP JPY 6.41T 451.4B
Vanda Pharmaceuticals VNDA:US USD 559M 57M